Clinical Trials on LV Lead in Norway

Total 75 results

Oslo University Hospital

Active, not recruiting

Dose Painting of Head and Neck Cancer (RADPAINT)

Head and Neck Cancer

Norway
Oslo University Hospital

Active, not recruiting

RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck (RADPAINT-2)

Head and Neck Cancer

Norway
University of Oslo
Oslo University Hospital; University of South-Eastern Norway

Not yet recruiting

Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home (NUTREAT)

Head and Neck Cancer

Norway
Oslo University Hospital
Bristol-Myers Squibb

Recruiting

REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors (REPORT)

Head and Neck Squamous Cell Carcinoma

Norway
Oslo University Hospital
Norwegian Cancer Society

Active, not recruiting

ReIrradiation With FDG-PET Guided Dose Painting (RIDPAINT)

Head and Neck Cancer

Norway
Norwegian University of Science and Technology
St. Olavs Hospital; Helse Midt-Norge

Completed

Acute and Longlasting Side Effects Caused by Radiotherapy in the Head and Neck Area

Head and Neck Cancer

Norway
Norwegian University of Science and Technology
University Hospital of North Norway; University of Bergen; St. Olavs Hospital

Recruiting

The EMINENCE Study - PET/MR Imaging of Head Neck Cancer (EMINENCE)

Head and Neck Neoplasms

Norway
Norwegian University of Science and Technology
Oslo University Hospital; St. Olavs Hospital; LHL-Klinikkene, Røros

Completed

Rehabilitation for Head and Neck Cancer

Head and Neck Neoplasms

Norway
Oslo University Hospital
University of Oslo

Completed

H&N Cancer; Survivorship and Late Effects

Head and Neck Neoplasms | Survivorship

Norway
Oslo University Hospital
Oslo University College

Completed

Vestibular Rehabilitation and Balance Training After Traumatic Brain Injury (VRTBI2012)

Dizziness | Traumatic Brain Injury | Brain Concussion | Head Injury

Norway
Oslo University Hospital
Oslo Metropolitan University

Recruiting

Radiotherapy of Head and Neck Cancer Using an Intraoral Stent

Oral Cavity Cancer | Sinonasal Cancer

Norway
Oslo University Hospital
Oslo Metropolitan University

Completed

Radiotherapy of Tongue Cancer Using an Intraoral Stent

Tongue Cancer

Norway
Oslo University Hospital
Bristol-Myers Squibb

Active, not recruiting

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Esophageal Cancer

Norway
Oslo University Hospital

Recruiting

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders (MITRIC)

Clear Cell Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Melanoma Stage IV | Cutaneous Squamous Cell Carcinoma | MSI-High

Norway
St. Olavs Hospital
Norwegian University of Science and Technology

Completed

Exercise in Patients With Post-Concussion Symptoms

Craniocerebral Trauma | Mild Traumatic Brain Injury | Head Injury, Minor | Posttraumatic Headache | Postconcussion Syndrome

Norway
Oslo University Hospital
Norwegian Cancer Society; Norwegian Foundation for Health and Rehabilitation

Terminated

Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only (PACO)

Esophageal Neoplasm

Norway
Oslo University Hospital

Active, not recruiting

Sub-symptom Threshold Aerobic Exercise After Mild Traumatic Brain Injury

Mild Traumatic Brain Injury

Norway
Oslo University Hospital

Recruiting

HRQOL in Thyroid Cancer and Thyroid Tumours

Quality of Life | Thyroid Cancer | Thyroid Nodule

Norway
St. Olavs Hospital
Norwegian University of Science and Technology

Recruiting

Acceptance and Commitment Therapy-based Rehabilitation of Post-concussion Symptoms

Post-Concussion Syndrome | Post-Traumatic Headache

Norway
Oslo University Hospital
Sophies Minde Foundation

Enrolling by invitation

Perthes Disease in Norway

Legg Calve Perthes Disease

Norway
St. Olavs Hospital

Active, not recruiting

Digital Solutions for Concussion (DiSCo)

Post-Concussion Syndrome | Post-Traumatic Headache

Norway
St. Olavs Hospital

Recruiting

Exercise in Postconcussion Symptoms and Posttraumatic Headache

Craniocerebral Trauma | Brain Concussion | Post-Concussion Syndrome | Post-Traumatic Headache

Norway
Sunnaas Rehabilitation Hospital
Oslo University Hospital; Oslo Metropolitan University

Recruiting

Effect of Graded Aerobic Exercise in Mild Traumatic Brain Injury

Traumatic Brain Injury | Mild Traumatic Brain Injury

Norway
Norwegian University of Science and Technology

Completed

Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury

Brain Injuries | Post-Concussive Symptom | Post-Concussive Syndrome

Norway
Oslo University Hospital
University Hospital, Akershus

Completed

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

Cervical Cancer | Cervical Intraepithelial Neoplasia | Oropharyngeal Cancer

Norway
Oslo University Hospital

Terminated

Coxib-inhibition of Duodenal Polyp Growth in FAP

Duodenal Polyposis

Norway
Haukeland University Hospital
Ullevaal University Hospital; Stiftelsen Helse og Rehabilitering

Completed

Multidisciplinary Treatment in Patients With Mild Traumatic Brain Injury

Traumatic Brain Injury With Brief Loss of Consciousness

Norway
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

Rhinitis | Chronic Disease | Nasal Polyposis

Norway
Lund University Hospital

Active, not recruiting

Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. (INTENSE)

Resectable Gastric and Gastroesophageal Junction Adenocarcinoma

Sweden, Norway
Karolinska University Hospital

Unknown

TaxXel: Taxotere and Xeloda in Esophageal Cancer (TaxXel)

Cancer of the Esophagus | Gastric Cardia Carcinoma

Norway, Sweden
European Organisation for Research and Treatment...
Merck KGaA, Darmstadt, Germany

Recruiting

Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (RAVINA)

Locally Advanced Head and Neck Squamous Cell Carcinoma

France, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
Halmstad County Hospital

Recruiting

Validation of the Scandinavian Guidelines for Minor and Moderate Head Trauma in Children (SHIPP)

Brain Injuries, Traumatic

Sweden, Norway
Lytix Biopharma AS
ICON plc; Theradex

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Melanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast Cancer

United Kingdom, France, Norway, Belgium, Italy
Karolinska University Hospital
The Swedish Research Council; University of Leipzig

Recruiting

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer (NEEDS)

Esophageal Squamous Cell Carcinoma

Canada, Sweden, Norway, Ireland
Abbott Medical Devices

Completed

Lead Registry for Optim Leads (OPTIMUM)

Optim Lead Insulation Related Adverse Events

United States, Belgium, Germany
Zimmer Biomet

Recruiting

Avenir Complete Post-Market Clinical Follow-Up Study

Osteoarthritis, Hip | Avascular Necrosis of Hip | Post-traumatic; Arthrosis | Avascular Necrosis of the Femoral Head

United States, Denmark, Japan, Netherlands, Norway, Sweden
Merck Sharp & Dohme LLC

Completed

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States, Australia, Austria, Brazil, France, Israel, Korea, Republic of, Norway, Spain, United Kingdom
European Organisation for Research and Treatment...

Completed

Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus

Esophageal Cancer

France, Sweden, United Kingdom, Germany, Switzerland, Spain, Australia, Norway
SciClone Pharmaceuticals

Completed

Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer (SCV-07 OM)

Head and Neck Cancer | Oral Mucositis

United States
AstraZeneca

Completed

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

Squamous Cell Carcinoma of the Head and Neck

Croatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
Genzyme, a Sanofi Company

Completed

Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer

Thyroid Neoplasms

Sweden, France, Spain, Norway, Belgium, Denmark, Switzerland
GlaxoSmithKline
iTeos Therapeutics

Recruiting

Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Neoplasms, Head and Neck

United States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
Bristol-Myers Squibb

Completed

Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (CheckMate 714)

Head and Neck Cancer

United States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
GlaxoSmithKline

Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (JADE)

Neoplasms, Head and Neck

United States, Italy, Japan, Norway, Spain, Taiwan, Australia, United Kingdom, Belgium, Brazil, Germany, Greece, Romania, Sweden, Turkey, Canada, Korea, Republic of, China, France, Argentina, India, Poland, Israel, Portugal, Mexico, Czechia, Hunga...
GlaxoSmithKline
Merck Sharp & Dohme LLC

Terminated

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3)

Neoplasms, Head and Neck

United States, Argentina, Australia, Spain, Taiwan, Germany, Israel, Poland, Canada, Japan, Portugal, Ireland, Netherlands, China, Brazil, France, Korea, Republic of, Italy, Romania, Russian Federation, United Kingdom, Norway, Switz... and more
Kura Oncology, Inc.

Completed

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy (AIM-HN/SEQ-HN)

HNSCC | HRAS Gene Mutation

United States, Belgium, Spain, United Kingdom, Taiwan, Denmark, Korea, Republic of, Netherlands, Thailand, Germany, Malaysia, Austria, Italy, Greece, Australia, Norway
SciClone Pharmaceuticals

Unknown

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Oral Mucositis

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States, Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

United States, Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer

Head and Neck Cancer

United States, Canada

Clinical Trials on LV Lead in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations